Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Merck
McKesson
Johnson and Johnson
Mallinckrodt

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Nomegestrol

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Nomegestrol: Patents, clinical trial progress, indications

Nomegestrol is an investigational drug.

There have been 15 clinical trials for Nomegestrol. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2016.

The most common disease conditions in clinical trials are Thrombophilia, Multiple Sclerosis, and Menorrhagia. The leading clinical trial sponsors are Merck Sharp & Dohme Corp., Mahidol University, and Grünenthal GmbH.

There are one hundred and twenty-two US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Nomegestrol
TitleSponsorPhase
Bioequivalence of Two Fixed-dose Combination Tablets Containing Estradiol and Nomegestrol AcetateGrünenthal S.A.Phase 1
Bioequivalence of Two Fixed-dose Combination Tablets Containing Estradiol and Nomegestrol AcetateGrünenthal GmbHPhase 1
Ovulation and Follicular Development Associated With Mid Follicular Phase Initiation of Combined Hormonal ContraceptionMahidol UniversityPhase 4

See all Nomegestrol clinical trials

Clinical Trial Summary for Nomegestrol

Top disease conditions for Nomegestrol
Top clinical trial sponsors for Nomegestrol

See all Nomegestrol clinical trials

US Patents for Nomegestrol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Nomegestrol   Start Trial Methods and devices for minimally-invasive delivery of radiation to the eye Salutaris Medical Devices, Inc. (Tucson, AZ)   Start Trial
Nomegestrol   Start Trial Methods for treatment of incontinence associated with sexual activity Allergan, Inc. (Irvine, CA)   Start Trial
Nomegestrol   Start Trial Formulations and methods for vaginal delivery of antiprogestins   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Colorcon
Boehringer Ingelheim
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.